Evidence map›Paper›PMID 31116632›Full record

ArticleHuman vaccines & immunotherapeutics2019

Prophylactic and therapeutic protection of human IgG purified from sera containing anti-exotoxin A titers against pneumonia caused by

Jin Zhang, Chuang Wan, Bo Yu, Chen Gao, Liqun Zhao, Xin Cheng, Feng Yang, Hao Gu, Quanming Zou, Jiang Gu and 1 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jin ZhangDepartment of Pediatric Research Institute, Children's Hospital of Chongqing Medical University, Chongqing, China.
Chuang WanNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, PR China.
Bo YuDepartment of Dermatology and Rheumatology Immunology, Xinqiao Hospital, Third Military Medical University, Chongqing, PR China.
Chen GaoNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, PR China.
Liqun ZhaoNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, PR China.
Xin ChengNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, PR China.
Feng YangNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, PR China.
Hao GuNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, PR China.
Quanming ZouNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, PR China.
Jiang GuNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, PR China.
Xingyong WangDepartment of Pediatric Research Institute, Children's Hospital of Chongqing Medical University, Chongqing, China.
Army Medical University · CNChina International Science and Technology Cooperation · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibodies are effective alternative tools to combat infections caused by

Indexed as

Immunization, PassiveADP Ribose TransferasesAnimalsAntibodies, BacterialAntibodies, NeutralizingBacterial ToxinsExotoxinsFemaleHumansImmunoglobulin GImmunoglobulins, IntravenousMicePneumonia, BacterialPseudomonas aeruginosaPseudomonas aeruginosa Exotoxin APseudomonas InfectionsADP Ribose TransferasesAntibodies, BacterialAntibodies, NeutralizingBacterial ToxinsExotoxinsImmunoglobulin GImmunoglobulins, IntravenousPseudomonas aeruginosa Exotoxin AVirulence Factorsexotoxin Ahuman intravenous immunoglobulinPseudomonas aeruginosatherapy

Identifiers

PMID31116632
PMCPMC6930096
OpenAlexW2946035185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.